Search
Returning search results with filters:
Remove filter for
Last updated: April 2020
Remove filter for
Last updated: 2020
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 10 of 10 items.
Importation of US-Labelled Vecuronium Bromide for Injection due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled QUELICIN (succinylcholine chloride injection) due to Shortage of Canadian-labelled QUELICIN
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Rocuronium Bromide Injection Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
AlertInformation update | 2020-04-25
Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection
AlertHealth professional risk communication | 2020-04-17
Shortage of salbutamol inhalers in Canada
AlertPublic advisory | 2020-04-17
Fraudulent and unauthorized N95 respirators may not protect consumers against COVID-19
AlertPublic advisory | 2020-04-14
Homemade hand sanitizers may present health risks
AlertPublic advisory | 2020-04-02